LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

ResMed Inc

Fechado

SetorSaúde

244.41 -0.44

Visão Geral

Variação de preço das ações

24h

Atual

Mín

242.26

Máximo

247.79

Indicadores-chave

By Trading Economics

Rendimento

-31M

349M

Vendas

-12M

1.3B

P/E

Médio do Setor

25.073

106.172

EPS

2.55

Rendimento de Dividendos

0.9

Margem de lucro

26.096

Funcionários

10,600

EBITDA

-29M

503M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+22.88% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.90%

2.31%

Próxima data de dividendos

18 de dez. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-2.1B

36B

Abertura anterior

244.85

Fecho anterior

244.41

Sentimento de Notícias

By Acuity

32%

68%

87 / 374 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de nov. de 2025, 23:36 UTC

Ações em Alta

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 de nov. de 2025, 22:13 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 de nov. de 2025, 21:55 UTC

Grandes Movimentos do Mercado

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 de nov. de 2025, 21:43 UTC

Aquisições, Fusões, Aquisições de Empresas

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 de nov. de 2025, 23:55 UTC

Conversa de Mercado

Gold Rises on Possible Investment Demand -- Market Talk

19 de nov. de 2025, 23:54 UTC

Conversa de Mercado

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 de nov. de 2025, 23:47 UTC

Ganhos

Lenovo Group 2Q EPS $2.52 >0992.HK

19 de nov. de 2025, 23:46 UTC

Ganhos

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 de nov. de 2025, 23:45 UTC

Ganhos

Lenovo Group 2Q Rev $20.5B >0992.HK

19 de nov. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 de nov. de 2025, 23:42 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

19 de nov. de 2025, 23:41 UTC

Ganhos

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 de nov. de 2025, 23:41 UTC

Ganhos

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 de nov. de 2025, 23:40 UTC

Ganhos

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 de nov. de 2025, 22:55 UTC

Ganhos

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 de nov. de 2025, 22:41 UTC

Ganhos

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 de nov. de 2025, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 de nov. de 2025, 22:30 UTC

Ganhos

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 de nov. de 2025, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 de nov. de 2025, 22:27 UTC

Aquisições, Fusões, Aquisições de Empresas

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 de nov. de 2025, 22:08 UTC

Ganhos

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 de nov. de 2025, 22:00 UTC

Ganhos

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 de nov. de 2025, 21:58 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 de nov. de 2025, 21:52 UTC

Ganhos

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 de nov. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

19 de nov. de 2025, 21:49 UTC

Conversa de Mercado
Ganhos

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 de nov. de 2025, 21:38 UTC

Ganhos

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 de nov. de 2025, 21:28 UTC

Aquisições, Fusões, Aquisições de Empresas

Palo Alto Networks to Buy Chronosphere for $3.35B

19 de nov. de 2025, 21:27 UTC

Aquisições, Fusões, Aquisições de Empresas

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 de nov. de 2025, 21:24 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

22.88% parte superior

Previsão para 12 meses

Média 302.56 USD  22.88%

Máximo 335 USD

Mínimo 270 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

9

Comprar

4

Manter

0

Vender

Sentimento

By Acuity

87 / 374 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat